CBLI Insider Trading Activity and SEC Form 4 Filings
CBLI insider trading summary
No open-market insider purchases or sales of Cleveland Biolabs Inc (CBLI) have been reported on SEC Form 4 in the past 12 months.
Latest CBLI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 25, 2015 | Randy S. Saluck | Director | Buy | $6K (1,891 @ $3.42) |
| May 21, 2013 | Paul E DiCorleto | Director | Buy | $10K (6,210 @ $1.61) |
| May 17, 2013 | Randy S. Saluck | Director | Buy | $6K (3,500 @ $1.60) |
| Mar 15, 2013 | James Antal | Director | Buy | $6K (3,700 @ $1.56) |
| Sep 21, 2012 | James Antal | Director | Buy | $6K (2,316 @ $2.60) |
| Jul 2, 2012 | David C Hohn | Director | Buy | $2K (1,000 @ $1.61) |
| Jun 15, 2012 | James Antal | Director | Buy | $6K (3,400 @ $1.76) |
| Apr 4, 2012 | David C Hohn | Director | Buy | $2K (1,000 @ $1.71) |
| Mar 20, 2012 | Michael Fonstein | President | Sell | $59K (20,000 @ $2.94) |
| Mar 19, 2012 | Michael Fonstein | President | Sell | $108K (35,601 @ $3.04) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.